GLP-3 (RT) is a synthetic peptide engineered as a triple receptor agonist, with binding affinity for GLP-1, GIP, and glucagon receptors. The triple-receptor mechanism represents the newest characterized class in incretin pathway research literature, with studies investigating multi-receptor signaling, glucose-substrate regulation, and metabolic pathway modeling.

Each Perplexa lot is independently verified by HPLC purity analysis with identity confirmed by mass spectrometry. The lot-specific Certificate of Analysis is published on this product page before the lot ships, including chromatograms, MS reports, and identity verification. The 60MG variant ships in a 10mL vial; the 10MG and 30MG variants ship in standard 3mL vials.

This material is supplied for in vitro research only. It is not a drug, supplement, food, or cosmetic, and is not for human or veterinary consumption.